Pfizer Inc. (PFE)

Pfizer Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	55,094	58,496	100,330	81,288	41,651	40,905
Revenue Growth (YoY)	-40.86%	-41.70%	23.43%	95.16%	1.82%	0.20%
Cost of Revenue	23,448	24,954	34,344	30,821	8,484	8,054
Gross Profit	31,646	33,542	65,986	50,467	33,167	32,851
Selling, General & Admin	14,848	14,771	13,677	12,703	11,597	12,726
Research & Development	10,667	10,679	11,428	10,360	8,709	8,385
Other Operating Expenses	7,922	7,035	6,154	3,093	5,824	8,527
Operating Expenses	33,437	32,485	31,259	26,156	26,130	29,638
Operating Income	-1,791	1,057	34,727	24,311	7,037	3,213
Other Expense / Income	55	53	27	479	-2,492	-13,397
Pretax Income	-1,846	1,004	34,700	23,832	9,529	16,610
Income Tax	-1,537	-1,115	3,328	1,852	370	583
Net Income	-309	2,119	31,372	21,980	9,159	16,027
Preferred Dividends	0	0	0	1	0	1
Net Income Common	-309	2,119	31,372	21,979	9,159	16,026
Net Income Growth	-	-93.25%	42.74%	139.97%	-42.85%	43.69%
Shares Outstanding (Basic)	5,657	5,643	5,608	5,601	5,555	5,569
Shares Outstanding (Diluted)	5,697	5,709	5,733	5,708	5,632	5,675
Shares Change	-0.52%	-0.42%	0.44%	1.35%	-0.76%	-5.05%
EPS (Basic)	-0.05	0.38	5.59	3.92	1.65	2.88
EPS (Diluted)	-0.05	0.37	5.47	3.85	1.63	2.82
EPS Growth	-	-93.24%	42.08%	136.20%	-42.20%	50.80%
Free Cash Flow	5,106	4,793	26,031	29,869	12,177	10,542
Free Cash Flow Per Share	0.90	0.85	4.64	5.33	2.19	1.89
Dividend Per Share	1.650	1.640	1.600	1.560	1.520	1.440
Dividend Growth	2.48%	2.50%	2.56%	2.63%	5.56%	5.88%
Gross Margin	57.44%	57.34%	65.77%	62.08%	79.63%	80.31%
Operating Margin	-3.25%	1.81%	34.61%	29.91%	16.90%	7.85%
Profit Margin	-0.56%	3.62%	31.27%	27.04%	21.99%	39.18%
Free Cash Flow Margin	9.27%	8.19%	25.95%	36.74%	29.24%	25.77%
Effective Tax Rate	-	-111.06%	9.59%	7.77%	3.88%	3.51%
EBITDA	4,693	7,294	39,764	29,023	14,210	22,365
EBITDA Margin	8.52%	12.47%	39.63%	35.70%	34.12%	54.68%
Depreciation & Amortization	6,539	6,290	5,064	5,191	4,681	5,755
EBIT	-1,846	1,004	34,700	23,832	9,529	16,610
EBIT Margin	-3.35%	1.72%	34.59%	29.32%	22.88%	40.61%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).